A 42-year-old woman with newly diagnosed leprosy is being classified according to the Ridley-Jopling system. Which of the following statements about leprosy classification is NOT true?

Explanation

## Stability and Progression in Ridley-Jopling Classification A critical concept in leprosy classification is the **stability** of each form and its **prognostic implications**. Indeterminate leprosy is often misunderstood as stable, but it is actually the **most unstable** form. ### Stability Spectrum | Type | Stability | Progression Risk | Clinical Significance | |------|-----------|------------------|----------------------| | **Tuberculoid (TT)** | Stable | Low (may regress with treatment) | Best prognosis | | **Borderline Tuberculoid (BT)** | Relatively stable | Moderate | Good response to MDT | | **Mid-Borderline (BB)** | Unstable | High | Prone to reversal reactions | | **Borderline Lepromatous (BL)** | Unstable | High | Prone to reversal reactions | | **Lepromatous (LL)** | Stable (untreated) | Moderate (with treatment) | Worst prognosis untreated | | **Indeterminate** | **UNSTABLE** | **Very high** | **Must be reclassified** | ### Why Option 3 Is Incorrect **Key Point:** Indeterminate leprosy is **NOT stable**. It is the **earliest, most unstable form** that **must progress** to one of the five defined types within weeks to months, depending on the host's immune response. **High-Yield:** Indeterminate leprosy is a **temporary classification**. It will evolve toward: - **Tuberculoid pole** (TT/BT) if cell-mediated immunity develops - **Lepromatous pole** (BL/LL) if cell-mediated immunity fails **Clinical Pearl:** A patient presenting with indeterminate leprosy should be **re-examined and reclassified** after 4–6 weeks to determine the true immunological type. Delaying this reclassification can lead to inappropriate treatment decisions. ### Correct Features (Options 1, 2, 4) 1. **Borderline lepromatous (BL)** has asymmetric lesions with bacterial index 4–5+ — this is textbook. 2. **Immunity-lesion correlation:** Strong immunity (TT) → few lesions; weak immunity (LL) → many lesions. This is the fundamental principle of the spectrum. 3. **Lepromatous dissemination:** LL involves eyes (iritis, keratitis), testes (orchitis, infertility), nose (nasal collapse), peripheral nerves, and systemic organs due to high bacillary load. **Mnemonic: "I for Indeterminate = Intermediate/Unstable"** — Remember that indeterminate is a **transitional state**, not an endpoint.